Interestingly, glutamine, the transport substrate of VNUT (SLC17A9), plays a regulatory role in insulin secretion, and therefore, clodronate has been demonstrated to have therapeutic effects on T2D and NASH in mice models (Hasuzawa et al., 2021). This evidence concerns the gene INS and type 2 diabetes mellitus.